Normalized Pre-Tax Income: A company's income before income tax expense smoothed out by removing non-recurring items.
Boston Scientific Corporation (BSX) had Normalized Pre-Tax Income of $939.00M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$5.07B |
|
$755.00M |
|
$1.52B |
|
$3.54B |
|
$4.02B |
|
$1.05B |
|
$-110.00M |
|
$939.00M |
|
|
Normalized Pre-Tax Income |
$939.00M |
$756.00M |
|
$756.00M |
|
$755.00M |
|
$756.00M |
|
$1.05B |
|
-- |
|
1.48B |
|
1.50B |
|
$0.51 |
|
$0.51 |
|
| Balance Sheet Financials | |
-- |
|
-- |
|
-- |
|
$0.00M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Cash Flow Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|